Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF – Get Free Report) saw a significant decline in short interest during the month of September. As of September 15th, there was short interest totaling 10,416 shares, a decline of 66.5% from the August 31st total of 31,081 shares. Based on an average trading volume of 6,751 shares, the short-interest ratio is currently 1.5 days.
Analysts Set New Price Targets
FSPKF has been the subject of several research analyst reports. Citigroup upgraded shares of Fisher & Paykel Healthcare to a “buy” rating in a research report on Thursday, September 10th. Royal Bank Of Canada upgraded Fisher & Paykel Healthcare from a “sector perform” rating to an “outperform” rating in a research report on Tuesday, September 15th. Two equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Fisher & Paykel Healthcare presently has a consensus rating of “Buy”.
Get Our Latest Stock Analysis on FSPKF
Fisher & Paykel Healthcare Stock Up 1.6%
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical device company that develops, manufactures and markets products for respiratory care, acute care and the treatment of obstructive sleep apnea. The company’s offerings are designed for use in hospitals, intensive care units, operating rooms and homes.
Its product portfolio includes respiratory humidification systems, nasal high-flow therapy systems, noninvasive ventilation equipment, continuous positive airway pressure (CPAP) and bilevel masks, neonatal respiratory care products, and related consumables and accessories.
Further Reading
- Five stocks we like better than Fisher & Paykel Healthcare
- Six Flags Launches FlexPay—Is There Any FUN Left in the Stock?
- Brewing Trouble? Starbucks Spills the Beans on 250 Store Closures
- Stitch Fix Stock Plunges as Guidance Puts the Turnaround on Pause
- Harley-Davidson Insiders Are Buying: Is HOG Finally Turning Around?
Receive News & Ratings for Fisher & Paykel Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fisher & Paykel Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
